These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 12003383)

  • 21. Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients.
    Lam KY; Lo CY
    Am J Gastroenterol; 1998 Aug; 93(8):1232-5. PubMed ID: 9707043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
    Tomita T; Iwata K
    Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases.
    Zerbi A; Falconi M; Rindi G; Delle Fave G; Tomassetti P; Pasquali C; Capitanio V; Boninsegna L; Di Carlo V;
    Am J Gastroenterol; 2010 Jun; 105(6):1421-9. PubMed ID: 20087335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.
    Rigaud G; Missiaglia E; Moore PS; Zamboni G; Falconi M; Talamini G; Pesci A; Baron A; Lissandrini D; Rindi G; Grigolato P; Pederzoli P; Scarpa A
    Cancer Res; 2001 Jan; 61(1):285-92. PubMed ID: 11196176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation.
    Lewis RB; Lattin GE; Paal E
    Radiographics; 2010 Oct; 30(6):1445-64. PubMed ID: 21071369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
    Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
    Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression.
    Chang MC; Xiao S; Nosé V
    Hum Pathol; 2007 May; 38(5):732-40. PubMed ID: 17306326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
    Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous fat necrosis as the presenting feature of a pancreatic carcinoma: the challenge of differentiating endocrine and acinar pancreatic neoplasms.
    Martin SK; Agarwal G; Lynch GR
    Pancreas; 2009 Mar; 38(2):219-22. PubMed ID: 19238022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
    Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G
    Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic neoplasms in childhood and adolescence.
    Park M; Koh KN; Kim BE; Im HJ; Kim DY; Seo JJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):295-300. PubMed ID: 21464765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
    Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
    Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic head carcinoma: clinical analysis of 189 cases.
    Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pancreatic endocrine tumors].
    Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
    Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.